Sanofi-Aventis S.A. ADR (SNY)

$49.25 0.22 (0.45%)

15:58 EDT SNY Stock Quote Delayed 30 Minutes

3 Dividend Stocks to Buy in June 2024 for Dependable Dividend Growth

By Nikolaos Sismanis, InvestorPlace Contributor Jun 3, 2024

Explore three reliable dividend growth stocks for June 2024 to expand your investment profits for the second half of the year.

NVAX Stock Alert: Novavax Just Hit a New 52-Week High

Why Is Novavax (NVAX) Stock Up 118% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Volume:

Previous Close -

Market Cap 61.60B

PE Ratio -

EPS -

Volume (Avg. Vol.) 1.65M

Day's Range $48.50 - $49.40

52-Week Range $42.63 - $55.72

Dividend & Yield $1.90 (3.86%)

SNY Stock Predictions, Articles, and Sanofi-Aventis S.A. ADR News

From InvestorPlace
From the Web

3 Biotech Stocks to Sell in May Before They Crash & Burn

By Shane Neagle, InvestorPlace Contributor May 10, 2024

Discover essential insights on biotech stocks to sell in May to navigate market volatility and safeguard your investment portfolio.

The 3 Most Undervalued Pharma Stocks to Buy in May 2024

By Viktor Zarev, InvestorPlace Contributor May 9, 2024

Investors looking for good deals in the pharmaceutical industry should watch out for these three undervalued pharma stocks.

SNY Stock Earnings: Sanofi Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings Apr 25, 2024

SNY stock results show that Sanofi beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Sanofi Layoffs 2024: What to Know About the Latest SNY Job Cuts

By William White, InvestorPlace Writer Apr 8, 2024

Sanofi layoffs are coming for the company's R&D employees and it makes major changes to how it handles development going forward.

Passport to Profits: 7 Global Growth Gems to Diversify Your Holdings

By Josh Enomoto, InvestorPlace Contributor Mar 13, 2024

With certain sectors in the domestic market appearing overstretched, these global growth stocks may offer better opportunities.

Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits

By Will Ashworth, InvestorPlace Contributor Mar 4, 2024

Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising.

3 Cash Cow Dividend Stocks for Outsized Income & Upside

By Josh Enomoto, InvestorPlace Contributor Feb 27, 2024

Following another shaky day in the market, investors may want to consider cash cow dividend stocks. They’re not sexy and they probably won’t make you…

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

By Josh Enomoto, InvestorPlace Contributor Feb 15, 2024

Last October, life sciences giant Thermo Fisher Scientific (NYSE:TMO) inadvertently laid out the case for contrarian biotech stocks. According to Reuters, the company revealed that…

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar

By Josh Enomoto, InvestorPlace Contributor Dec 17, 2023

With so many innovative firms skyrocketing this year, astute investors seeking compelling discounts may want to turn their attention to undervalued biotech picks. Just like…

SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff

By Dana Blankenhorn, InvestorPlace Contributor Oct 27, 2023

The happy talk in Sanofi's press release didn't help with analysts, who have been disappointed in the company and SNY stock all year.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Oct 27, 2023

It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!

3 Stocks to Buy to Ride Europe’s Coming Market Surge

By Will Ashworth, InvestorPlace Contributor Sep 19, 2023

With Europe’s markets looking to perform better in the second half of 2023, here are three European stocks to buy to ride the wave.

7 Blue-Chip Stocks That Are Screaming Buys Right Now: July 2023

By Josh Enomoto, InvestorPlace Contributor Jul 23, 2023

Even some of the top players of the market don’t get the attention they deserve, making these blue-chip stocks compelling.

The 7 Most Reliable Dividend Stocks to Buy Now

By Josh Enomoto, InvestorPlace Contributor Jun 6, 2023

Faced with a tricky market backdrop, investors may take significant comfort with the most reliable dividend stocks to buy.

7 Blue-Chip Stocks to Buy in May 2023

By Josh Enomoto, InvestorPlace Contributor May 4, 2023

While not the most exciting sector available, rising fears in the market incentivizes the best blue-chip stocks to buy.

7 Stock Upgrades and Downgrades Alerts You Cannot Ignore

By Chris Lau, InvestorPlace Contributor May 4, 2023

Analyst stock upgrades and downgrades caught the market's attention in the last week and putting investors on notice for buys and sells.

Why Is Provention Bio (PRVB) Stock Up 263% Today?

By William White, InvestorPlace Writer Mar 13, 2023

Provention Bio (PRVB) stock is rocketing higher on Monday following news that Sanofi (SNY) is acquiring the company for $2.9 billion.

7 Blue-Chip Stocks to Buy for Quality-Focused Investors

By Josh Enomoto, InvestorPlace Contributor Mar 6, 2023

With circumstances shaky in the market right now, concerned investors may want to consider blue-chip stocks to buy.

Sanofi Layoffs 2023: What to Know About the Latest SNY Job Cuts

By Samuel O'Brient, InvestorPlace Reporter Jan 31, 2023

One pharmaceutical producer is implementing job cuts. Here's what investors need to know about the Sanofi layoffs.

7 Blue-Chip Stocks to Buy as a New Bull Market Emerges

By Alex Sirois, InvestorPlace Contributor Jan 26, 2023

Many blue-chip stocks look like a bargain right now, and these seven companies are certainly no exception.

Sanofi-Aventis S.A. ADR (SNY)

3 Dividend Stocks to Buy in June 2024 for Dependable Dividend Growth

NVAX Stock Alert: Novavax Just Hit a New 52-Week High

Why Is Novavax (NVAX) Stock Up 118% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Sanofi-Aventis S.A. ADR (SNY)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

SNY Stock Predictions, Articles, and Sanofi-Aventis S.A. ADR News

Subscriber Sign in